Grants to ViroPharma Sample Clauses

Grants to ViroPharma. 2.1.1. Subject to the terms and conditions of this Agreement, INS hereby grants to ViroPharma: (a) an exclusive (including with regard to INS and its Affiliates), royalty-bearing right and license, with the right to grant sublicenses in accordance with Section 2.2, under the INS Technology (excluding the INS Technology licensed to INS under the Academic License), to import, make, have made, use, sell, offer for sale, and otherwise Exploit Licensed Products in the Field in the Territory; (b) an exclusive (including with regard to INS and its Affiliates) right of reference, with the right to grant sublicenses and further rights of reference in accordance with Section 2.2, under the Regulatory Documentation Controlled by INS or any of its Affiliates, if any, to Exploit the Licensed Products in the Field in the Territory; and (c) subject to the terms of the Academic License, an exclusive sublicense to the INS Technology licensed to INS under the Academic License to import, make, have made, use, sell, offer for sale, and otherwise Exploit Licensed Products in the Territory.
AutoNDA by SimpleDocs
Grants to ViroPharma. Subject to the terms and conditions of this Agreement, Sanquin hereby grants to ViroPharma: 2.2.1 the exclusive (including with regard to Sanquin and its Affiliates (subject to the rights of Sanquin and its Affiliates as set out in Section 2.4)) right and license under the Sanquin Technology, to research, develop, import, use, sell and offer for sale each ViroPharma Product in the ViroPharma Territory, provided that such ViroPharma Product shall be manufactured by Sanquin (and its Affiliates and/or Sanquin’s subcontractors) as further set out in Article 5 hereof; 2.2.2 the exclusive (including with regard to Sanquin and its Affiliates (subject to the rights of Sanquin and its Affiliates as set out in Section 2.4)) right of reference under the Regulatory Documentation, to support Regulatory Approvals for the ViroPharma Product in the ViroPharma Territory, including the Cinryze Marketing Authorization; and 2.2.3 until ViroPharma has obtained Cinryze Marketing Authorization for Europe, the exclusive (including with regard to Sanquin and its Affiliates (subject to the rights of Sanquin and its Affiliates as set out in Section 2.4)) right and license, under the Sanquin Technology, to sell and offer for sale Cetor NF Product in ***, provided that such Cetor NF Product shall be manufactured by Sanquin (and its Affiliates and/or Sanquin’s subcontractors), and subject to ViroPharma giving notification to Sanquin of its intention to sell and offer for sale Cetor NF Product in such countries in a timely manner and Sanquin subsequently obtaining Cetor Marketing Authorization for such countries, it being understood that Sanquin shall use Commercially Reasonable Efforts to obtain Cetor Marketing Authorization for such countries.

Related to Grants to ViroPharma

  • Suits to Protect the Collateral Subject to the provisions of Article 6 hereof, the Indenture Trustee in its sole discretion and without the consent of the Holders, on behalf of the Holders, may take all actions it deems necessary or appropriate in order to: (a) enforce any of the terms of the Security Documents; and (b) collect and receive any and all amounts payable in respect of the Secured Obligations of the Issuer hereunder. Subject to the provisions of the Security Documents, the Indenture Trustee shall have power (but not the obligation) to institute and to maintain such suits and proceedings as it may deem expedient to prevent any impairment of the Collateral by any acts which may be unlawful or in violation of any of the Security Documents or this Indenture, and such suits and proceedings as the Indenture Trustee, in its sole discretion, may deem expedient to preserve or protect its interests and the interests of the Holders in the Collateral (including power to institute and maintain suits or proceedings to restrain the enforcement of or compliance with any legislative or other governmental enactment, rule or order that may be unconstitutional or otherwise invalid if the enforcement of, or compliance with, such enactment, rule or order would impair the Lien on the Collateral or be prejudicial to the interests of the Holders or the Indenture Trustee).

  • Agreements with Employees and Subcontractors Grantee shall have written, binding agreements with its employees and subcontractors that include provisions sufficient to give effect to and enable Grantee’s compliance with Grantee’s obligations under this Article VI, Intellectual Property.

  • DIPLOMATIC AND CONSULAR OFFICIALS Nothing in this Convention shall affect the fiscal privileges of diplomatic or consular officials under the general rules of international law or under the provisions of special agreements.

  • WHO NEEDS TO FILE THE SPR The principal or his/her authorized agent needs to complete and sign the SPR and warrant that the information provided on the SPR is true and correct. A principal that is a governmental entity does not need to file an SPR. Lobbying means seeking “to encourage the approval, disapproval, adoption, repeal, rescission, passage, defeat or modification of any ordinance, resolution, agreement, development permit, other type of permit, franchise, vendor, Contractor, contractor, recommendation, decision or other foreseeable action of the [BCC],” and “include[s] all communications, regardless of whether initiated by the lobbyist or by the person being lobbied, and regardless of whether oral, written or electronic.” (See Section 2-351, Orange County Code.) Furthermore, lobbying means communicating “directly with the County Mayor, with any other member of the [BCC], or with any member of a procurement committee.” (See Section 2-351, Orange County Code.) Lobbying also means communicating “indirectly with the County Mayor or any other member of the [BCC]” by communicating with any staff member of the Mayor or any member of the BCC, the county administrator, any deputy or assistant county administrator, the county attorney, any county department director, or any county division manager. (See Section 2-351, Orange County Code.) Lobbying does not include the act of appearing before a Sunshine Committee, such as the Development Review Committee or the Roadway Agreement Committee other than the BCC.

  • DIPLOMATIC AGENTS AND CONSULAR OFFICERS Nothing in this Agreement shall affect the fiscal privileges of diplomatic agents or consular officers under the general rules of international law or under the provisions of special agreements.

  • Warrants to Rank Pari Passu All Warrants shall rank equally and without preference over each other, whatever may be the actual date of issue thereof.

  • PAYMENTS TO PURCHASER 52 ARTICLE VI....................................................................54

  • Statements to Purchaser Not later than the tenth calendar day of the month, the Company shall furnish in an agreed upon electronic format to the Purchaser or its designee, a monthly, loan level, scheduled remittance advice, trial balance report and payment and payoff activity detail, as to the preceding remittance and the period ending on the last day of the preceding month.

  • Additional Promises by Individuals If you are a natural person (not an entity), you also promise that: 5.22.1. U.S. Citizen or Resident You are a citizen or permanent resident (green card) of the United States. 5.22.2. Financial Wherewithal You can afford this investment, even if you lose your money. You don’t rely on this money for your current needs, like rent or utilities. 5.22.3. Anti-Terrorism and Money Laundering Laws None of the money used to purchase the Note was derived from or related to any activity that is illegal under United States law, and you are not on any list of “Specially Designated Nationals” or known or suspected terrorists that has been generated by the Office of Foreign Assets Control of the United States Department of Treasury (“OFAC”), nor are you a citizen or resident of any country that is subject to embargo or trade sanctions enforced by OFAC.

  • Know-How Necessary for the Business The Intellectual Property Rights are all those necessary for the operation of the Company’s businesses as it is currently conducted or as represented, in writing, to the Purchasers to be conducted. The Company is the owner of all right, title, and interest in and to each of the Intellectual Property Rights, free and clear of all liens, security interests, charges, encumbrances, equities, and other adverse claims, and has the right to use all of the Intellectual Property Rights. To the Company’s knowledge, no employee of the Company has entered into any contract that restricts or limits in any way the scope or type of work in which the employee may be engaged or requires the employee to transfer, assign, or disclose information concerning his work to anyone other than of the Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!